Post Test - L.I.D. Listen, Identify, Diagnose*This post test is NOT required unless your state board requires one for CE credit. Please check with your individual state board. Name * First Name Last Name Email License State and Number All of the following are key aspects of empathy-based care except? Active listening Validating emotions Judgmental approach Cultural competency __________ In the morning is a common compliant reported by patients with DB? Blurry vision Redness Crusty lids Sore eyes What percentage of blepharitis is DB? 29% 69% 59% 19% The pathognomonic sign for DB is? Collarettes Lid erythema Ocular Rosacea Lash loss What percentage of the population is affected by DB? 10% 20% 30% 80% When diagnosing DB instruct the patient to _________. Look up Look down Look to the right Look to the left All the following are non-FDA Approved treatments for DB except: Tea Tree Oil Ivermectin Zouclar Gel Lotilaner ophthalmic solution, 0.25% The mechanism of action of Lotilaner involves targeting and killing the Demodex mites: Inhibiting GABA-gated chloride channels Activating GABA-gated chloride channels Innervating GABA-gated chloride channels Stimulating GABA-gate chloride channels The two pivotal trials (Saturn 1 and Saturn 2) what were the primary and secondary end points? Collarettes reduction less than or equal to 2, erythema cure and mite eradication on day 43 Collarettes reduction less than or equal to 1, erythema cure and mite eradication on day 14 Collarettes reduction less than or equal to 3, erythema cure and mite eradication on day 30 Collarettes reduction less than or equal to 10, erythema cure and mite eradication on day 43 What percentage of patients with MGD will DB? ~60% ~10% ~5% ~55% Thank you submitting your responses. They have been recorded. Please email us if you need a copy for your state board.
